At a glance
ClinicalIndex Comparison RecordN/ACompleted· 154 enrolled
Drug / intervention
Aerobic exercise trainingbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Accuracy of Digital Assessment of Performance Trial (ADAPT): Walk Test Study
In Brief
An observational study evaluating Aerobic exercise training for Parkinson Disease and COPD. Completed, enrolled 154 participants across 28 sites.
Detailed Summary
The aim of this study is to investigate whether a smartwatch can measure the physical capacity of patients with Parkinson's Disease and COPD in the physiotherapy practice and at home.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsParkinson Disease, COPD
CountriesNetherlands
CollaboratorsVerily Life Sciences LLC
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartDec 2021
First PostedMar 2023
Primary CompletionNov 2023
TodayJul 2026
First PostedMar 6, 2023
Enrollment StartDec 23, 2021
Primary CompletionNov 30, 2023
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 3.3 years ago
Interventions
Aerobic exercise trainingbehavioral
Participants will follow a personalized aerobic exercise training program twice a week at the physiotherapist. The intensity of the program is based on the results of the 6MWT according to the most recent guidelines for physiotherapy for PD and COPD